CDAM UK Ltd boosted its holdings in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) by 2.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 232,962 shares of the technology company’s stock after acquiring an additional 4,980 shares during the period. Veeva Systems makes up approximately 9.5% of CDAM UK Ltd’s investment portfolio, making the stock its 5th largest holding. CDAM UK Ltd’s holdings in Veeva Systems were worth $52,004,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Board of the Pension Protection Fund acquired a new stake in shares of Veeva Systems in the 4th quarter valued at about $27,000. Raiffeisen Bank International AG acquired a new stake in shares of Veeva Systems in the 3rd quarter valued at about $28,000. Newbridge Financial Services Group Inc. raised its stake in shares of Veeva Systems by 322.6% in the 4th quarter. Newbridge Financial Services Group Inc. now owns 131 shares of the technology company’s stock valued at $29,000 after purchasing an additional 100 shares during the period. Activest Wealth Management raised its stake in shares of Veeva Systems by 3,175.0% in the 4th quarter. Activest Wealth Management now owns 131 shares of the technology company’s stock valued at $29,000 after purchasing an additional 127 shares during the period. Finally, BOK Financial Private Wealth Inc. acquired a new stake in shares of Veeva Systems in the 4th quarter valued at about $33,000. 88.20% of the stock is currently owned by institutional investors.
Veeva Systems Stock Performance
NYSE:VEEV opened at $159.44 on Friday. The stock’s 50-day simple moving average is $165.06 and its 200 day simple moving average is $192.11. The company has a market cap of $25.90 billion, a P/E ratio of 28.42, a P/E/G ratio of 0.69 and a beta of 0.95. Veeva Systems Inc. has a 52-week low of $148.05 and a 52-week high of $310.50.
Wall Street Analyst Weigh In
Several research firms have issued reports on VEEV. BMO Capital Markets dropped their price target on Veeva Systems from $220.00 to $175.00 and set a “market perform” rating on the stock in a research note on Thursday, June 4th. Zacks Research downgraded Veeva Systems from a “strong-buy” rating to a “hold” rating in a research note on Thursday, May 14th. The Goldman Sachs Group dropped their price target on Veeva Systems from $190.00 to $165.00 and set a “sell” rating on the stock in a research note on Thursday, June 4th. Robert W. Baird lifted their price target on Veeva Systems from $250.00 to $260.00 and gave the company an “outperform” rating in a research note on Thursday, June 4th. Finally, Mizuho dropped their price target on Veeva Systems from $295.00 to $270.00 and set an “outperform” rating on the stock in a research note on Thursday, June 4th. Eighteen investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Veeva Systems presently has a consensus rating of “Moderate Buy” and an average price target of $250.96.
Read Our Latest Research Report on VEEV
Insider Activity
In related news, Director Priscilla Hung sold 750 shares of Veeva Systems stock in a transaction dated Thursday, April 30th. The stock was sold at an average price of $155.64, for a total value of $116,730.00. Following the sale, the director owned 3,253 shares of the company’s stock, valued at approximately $506,296.92. The trade was a 18.74% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 10.60% of the company’s stock.
Veeva Systems Company Profile
Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.
Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.
Featured Articles
- Five stocks we like better than Veeva Systems
- SpaceX Rings the Bell and Shatters Every Record
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
- 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
- The 127-Gigawatt Problem: Why AI Needs Its Own Power
Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV – Free Report).
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
